Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene® Mist
December 27, 2016 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., Dec. 27, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response...
Amphastar Pharmaceuticals to Present at the 2016 Piper Jaffray Healthcare Conference
November 28, 2016 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., Nov. 28, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 2016 Piper...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2016
November 08, 2016 16:05 ET
|
Amphastar Pharmaceuticals Inc.
Reports Net Revenues of $64.2 Million for the Three Months Ended September 30, 2016 RANCHO CUCAMONGA, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)...
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2016
October 28, 2016 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., Oct. 28, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2016 ended...
Amphastar Pharmaceuticals to Present at the 2016 Wells Fargo Healthcare Conference
September 01, 2016 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 2016 Wells Fargo...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2016
August 08, 2016 16:05 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended June 30,...
Amphastar Pharmaceuticals, Inc. Purchases International Medication Systems (UK) Limited from UCB PHARMA GmbH
August 04, 2016 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”), announced today that, through its wholly owned UK...
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2016
August 01, 2016 06:00 ET
|
Amphastar Pharmaceuticals Inc.
RANCHO CUCAMONGA, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2016 ended June...
Amphastar Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference
June 03, 2016 06:00 ET
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., June 03, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies 2016...
Amphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016
May 09, 2016 16:05 ET
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the first quarter ended March 31,...